Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer

WATERTOWN, Mass., Sept. 06, 2018 -- (Healthcare Sales & Marketing Network) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Manuel Aivado, MD... Biopharmaceuticals, Oncology, Personnel Aileron Therapeutics, stapled peptides, alpha-helical peptides
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news